Welcome to Hologic Investor Relations

Hologic, Inc. is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment.

The Company's Common Stock is listed on the Nasdaq Global Select Market under the trading symbol HOLX.

Recent and Upcoming Events
Thursday, February 8, 2018
4:30pm - 5:30pm EST

Dial-in numbers 800-281-7973 +1 323-792-2093 Passcode 4501215 Click here for replay

Recent News
Jan 22, 2018

Hologic's (Nasdaq: HOLX) Cynosure division announced today the launch of TempSure™ Envi – an FDA-cleared advanced radiofrequency device that minimizes facial fine lines and wrinkles, tightens...

Jan 16, 2018

Hologic, Inc. (Nasdaq: HOLX) announced today that it has priced and allocated its previously announced private offering of $1 billion in aggregate principal amount of senior notes as follows: (i)...

Jan 16, 2018

Hologic, Inc. (Nasdaq: HOLX) announced today that it has launched, subject to market and other conditions, a private offering of $1 billion in aggregate principal amount of senior notes, to be...

Jan 16, 2018

Hologic, Inc. (Nasdaq: HOLX) announced today that its CE-marked Aptima® HIV-1 Quant Dx assay has been awarded World Health Organization (WHO) prequalification for in vitro diagnostics. The Aptima...

More ›